Spitalul De Psihiatrie Titan Dr. Constantin Gorgos
- Address
- lock Available on a paid plan
Neoplasms
At Spitalul De Psihiatrie Titan Dr. Constantin Gorgos in Bucharest, clinical research is focused on neoplasms, with studies centered on improving care for patients with cancer. The trials are aimed at evaluating new treatment approaches and comparing how well different therapies help control disease and prevent recurrence.
- Lung cancer research, especially metastatic non-squamous NSCLC, is examining whether one PD-1 inhibitor strategy offers better treatment effectiveness than another when used with chemotherapy.
- Locally advanced cutaneous squamous cell carcinoma studies are assessing pembrolizumab as an adjuvant treatment to help reduce the risk of cancer returning after surgery.
This small but focused research portfolio reflects interest in both advanced solid tumors and post-surgical cancer control, with an emphasis on comparing treatment benefit and strengthening outcomes for patients with difficult-to-treat malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul De Psihiatrie Titan Dr. Constantin Gorgos
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630). | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Mar 2019 | Jan 2026 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 2 | Unknown | 2019-03-04 | 2020-11-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.